The safety of brodalumab for the treatment of psoriasis

Iznardo, H; Puig, L

Puig, L (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Dermatol, Mas Casanovas 90, Barcelona 08041, Spain.

EXPERT OPINION ON DRUG SAFETY, 2020; 19 (4): 365

Abstract

Introduction: Brodalumab is a newly developed targeted biologic agent for the treatment of psoriasis that blocks IL-17 receptor A. Areas covered: This......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索